Molecular Minimal Residual Disease Monitoring In Npm1-Mutated Acute Myeloid Leukemia: A Single Institution Experience
Introduction: The NPM1mut identification by RQ-PCR at diagnosis is important for AML risk stratification and represents a reliable marker to track minimal residual disease (MRD) and to early detect relapse. We retrospectively analyzed clinical and biological features of NPM1mut AML pts consecutively...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
MDPI AG
2020-09-01
|
| سلاسل: | Hematology Reports |
| الوصول للمادة أونلاين: | https://www.pagepress.org/journals/index.php/hr/article/view/8901 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
